Press "Enter" to skip to content

USFDA issues 9 observations to Natco Pharma’s Kothur facility

"At the end of the inspection, the facility received 9 observations, with no repeat observations and mostly procedural in nature," Natco Pharma said in a BSE filing.

Original source:

Also Read:   Counterfeit medicine a 'growing threat': EU study